WO1996041794A1 - Procede de preparation des formes enantiomeres de l'acide amino alkylaminophenyl propanoique - Google Patents
Procede de preparation des formes enantiomeres de l'acide amino alkylaminophenyl propanoique Download PDFInfo
- Publication number
- WO1996041794A1 WO1996041794A1 PCT/FR1996/000872 FR9600872W WO9641794A1 WO 1996041794 A1 WO1996041794 A1 WO 1996041794A1 FR 9600872 W FR9600872 W FR 9600872W WO 9641794 A1 WO9641794 A1 WO 9641794A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amino
- phenyl
- radical
- phenylalanine
- propanoic acid
- Prior art date
Links
- 0 *NC(Cc(cc1)ccc1[N+]([O-])=O)C(O)=O Chemical compound *NC(Cc(cc1)ccc1[N+]([O-])=O)C(O)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
Definitions
- the present invention relates to a process for the preparation of an enantiomeric form of 2-amino (4-alkylamino-phenyl) -3 propanoic acid of general formula:
- Alk represents an alkyl radical containing 1 to 2 carbon atoms and its salts.
- R is a hydrogen atom or a protective radical, is transformed into an alkylamino radical, after protection (if R is hydrogen), of the amino function of phenylalanine.
- Nitration is carried out with nitric acid in a sulfuric medium, at a temperature between -10 and -20 ° C.
- the transformation of the nitro radical into an alkylammo radical is carried out by alkylating reduction when the radical Alk is a methyl or ethyl radical, or by reduction, formylation of the amme obtained and subsequent reduction of the formylamino radical when the radical Alk represents methyl.
- the alkylating reduction is carried out by hydrogenation, under hydrogen pressure in the presence of Raney nickel, operating in methanol at a temperature between 20 and 40 ° C and under a pressure between 100 and 200 kPa.
- the alkylation is carried out under hydrogen pressure by adding benzaldehyde and then formaldehyde in the case where Alk is a methyl radical or ethanal in the case where Alk is an ethyl radical.
- the elimination of the amino protective radical and the elimination of the benzyl radical are carried out successively.
- the protective radical of the amino is an acetyl radical
- the elimination is carried out by treatment in an aqueous acid medium, in particular with hydrochloric acid.
- Alk is a methyl or ethyl radical
- the benzyl radical is removed by hydrogenation under hydrogen in the presence of palladium on carbon in an aqueous acid medium, in particular aqueous hydrochloric acid at a temperature between 50 and 60 ° C and under a pressure between 100 and 200 kPa.
- the phenylalanine derivative of general formula (I) is obtained in the form of a salt. Possibly it can be freed from its salt according to the usual methods which do not alter the rest of the molecule.
- the reduction of the nitro radical is carried out on the 4-nitro phenylalanine of general formula (II) whose amino function is protected by a radical R and the acid function of which has been previously protected, by operating in a reducing medium such as for example by treatment with zinc and ammonium chloride in a methanol-water mixture.
- the formylation of the amine obtained is carried out with formic acid, according to the usual methods of reacting an acid with an amino, which do not alter the rest of the molecule. In particular, one operates in tetrahydrofuran at a temperature between 0 and 25 ° C.
- the reduction of the formylamino radical thus formed is advantageously carried out by the boranes.
- the protection of the amine is carried out as described above.
- the protection of the carboxylic acid function is carried out according to known methods which do not alter the rest of the molecule, in particular by esterification.
- the protective radical of the amine and the protective radical of the acid are removed simultaneously by treatment in an aqueous acid medium, in particular with hydrochloric acid.
- the product of general formula (I) can optionally be purified by physical methods such as crystallization or chromatography.
- the product prepared according to the invention can either be obtained directly in the form of a salt or transformed into an addition salt with acids, into a metal salt or into an addition salt with nitrogenous bases according to the methods known per se.
- These salts can be obtained for example by the action of a metal base (for example alkaline or alkaline-earth), ammonia or an amine on a product according to the invention in a suitable solvent such as an alcohol, an ether or water or by exchange reaction with a salt of an organic acid.
- a metal base for example alkaline or alkaline-earth
- ammonia or an amine on a product according to the invention in a suitable solvent such as an alcohol, an ether or water or by exchange reaction with a salt of an organic acid.
- the salt formed precipitates after optional concentration of its solution, it is separated by filtration, decantation or lyophilization.
- salts there may be mentioned the salts with alkali metals (sodium, potassium, lithium) or with alkaline earth metals (magnesium, calcium), the ammonium salt, the salts of nitrogenous bases (ethanolamine, diethanolamine, trimethylamine, triethylamme, methylamine, propylamine, diisopropylamine, NN-dimethylethanolamine, benzylamine, dicyclohexylamine, N-benzyl phenethylamine, NN'-diben- zylethylenediamine, diphenylenediamine, benzhydrylamine, quinine, choline, arginine, lysine) addition salts with mineral acids (hydrochlorides, hydrobromides, sulfates, nitrates, phosphates) or organic acids (succinates, fumarates, maleates, methanesulfonates, p.toluenesulfonates, is
- the enantiomeric form of 2-amino (4-alkylamino-phenyl) -3 propanoic acid thus prepared by the process according to the invention can be useful in chemical synthesis.
- it can be used in the preparation of biologically active products and more particularly of synergistin derivatives such as pristinamycin IB or the corresponding ethylamino derivative, by operating from a strain of a microorganism producing streptogramins having at least one genetic modification affecting the biosynthesis of a precursor of group B streptogramins; said mutant strain is cultivated in a suitable culture medium, supplemented with the product prepared according to the invention, as an original precursor other than that whose biosynthesis is impaired.
- the strains used are strains producing natural streptogramins (pristinamycin, virginiamycin, etc.), mutated.
- the mutant strains have one or more genetic modifications at the level of at least one of their genes involved in the biosynthesis of the precursors of group B streptogramins. This or these genetic modifications alter the expression of said gene, that is to say say make this gene, and if necessary another of the genes involved in the biosynthesis of precursors, partially or completely incapable of coding for the natural enzyme involved in the biosynthesis of at least one precursor.
- the suspension is stirred for one hour at 0 ° C., then filtered.
- the white precipitate obtained is rinsed with 400 cm3 of water, drained, then dried under reduced pressure (20 kPa) at approximately 50 ° C.
- the mixture thus obtained is purged three times with nitrogen then three times with hydrogen before being placed under a hydrogen pressure of 100 kPa with vigorous stirring at a temperature in the region of 50 ° C for 2 hours and then brought to 20 ° C, filtered on clarcel, rinsed with 2 times 5.00 cm3 of water before being concentrated to dryness under reduced pressure (20 kPa) at a temperature close to 40 ° C. 12.90 cm3 of propanol-2 are added to the dry extract.
- the suspension thus obtained is brought to reflux for 1 hour, brought to a temperature in the region of 20 ° C, filtered, rinsed with 3.00 cm3 of propanol-2, wrung out and then dried under reduced pressure (20 kPa) at approximately 40 ° C .
- the precipitate obtained is filtered, taken up in 350 cm3 of water, brought to a temperature in the region of 50 ° C for 0.5 hour, brought to a temperature in the region of 20 ° C, filtered, drained and then dried under reduced pressure (20 kPa ) at about 40 ° C.
- Amino-2 [(N-methylamino) -4 phenyl] -3 propanoic acid (2S) can be obtained from acetamido-2 (4-nitro-phenyl) -3 propanoic acid (2S), as described in Example 1.
- the aqueous lower phase is withdrawn and the organic upper phase is poured into 2300 cm 3 of water at 20 ° C.
- the mixture is brought to reflux and 600 cm 3 of tetrahydrofuran are distilled.
- the suspension obtained is brought to 20 ° C with stirring, filtered, rinsed three times with 200 cm3 of water, wrung out and then dried under reduced pressure (20 kPa) at approximately 50 ° C.
- the mixture is stirred at 20 ° C for 30 minutes and then decanted.
- the lower organic phase is drawn off, dried over anhydrous sodium sulfate.
- the solution is concentrated at 30 ° C under reduced pressure (20 kPa) and then dried under reduced pressure (20 kPa) at approximately 25 ° C.
- the mixture is brought to reflux, the tetrahydrofuran is fractionated and then the mixture is brought to 25 ° C. and maintained at this temperature for 3 hours.
- the suspension obtained is filtered, rinsed with 150 cm3 of water, drained, dried under reduced pressure (20 kPa) at 40 ° C.
- the mixture is stirred at 25 ° C under nitrogen for 16 hours then concentrated under reduced pressure (20 kPa) at a temperature of 40 ° C.
- the mixture is allowed to return to 25 ° C. under nitrogen and then 1000 cm3 of dichloromethane and 1000 cm3 of a saturated aqueous solution of sodium chloride are added.
- the mixture is stirred for 30 minutes at 25 ° C. and then decanted.
- the lower organic phase is drawn off and dried over anhydrous sodium sulfate. After filtration of the sodium sulfate, the solution is concentrated at 30 ° C under reduced pressure (20 kPa).
- 95.1 g of 2-ethanamido (4-methylamino-phenyl) -3 methyl propanoate (2S) are thus obtained in the form of a white solid, melting at 151 ° C.
- a culture of the strain SP92 is carried out on the scale of 60 erlenmeyer flasks, as described below: pVRC508 in production medium with the addition at 16 hours of 1 ml of a 10 g / l solution in water 2-amino acid ((N-methylamino) -4 phenyl) -3 propanoic (2S).
- 2S 2-amino acid
- the 1.8 liters of must from 60 Erlenmeyer flasks are extracted with 2 volumes of a mixture of 66% 100 mM phosphate buffer pH 2.9 and 34% acetonitrile, then centrifuged. The supernatant is extracted with 2 times 0.5 volume of dichloromethane.
- the chloromethylenic phases are washed with water and then combined, dried over sodium sulfate and evaporated.
- the dry extract is taken up in 20 ml of dichloromethane and injected onto a silica column (30 g) mounted in dichloromethane and eluted successively in stages from 0 to 10% methanol in dichloromethane.
- the fractions containing the pristinamycin Ig are pooled and concentrated to dryness.
- the dry residue is taken up in 6 ml of a 65% water and 35% acetonitrile mixture and injected onto a Nucleosil 7 ⁇ C8 10x250 mm (Macherey Nagel) semi-preparative column eluted in a mixture of 65% 100 mM phosphate buffer pH 2.9 and 35% acetonitrile.
- the fractions containing pristinamycin Ig are combined and extracted with one volume of dichloromethane.
- the organic phase is washed with water, dried over sodium sulfate and then concentrated to dryness. 52 mg of pristinamycin Ig are obtained.
- the mutant SP92:: pVRC508 was cultured in a liquid production medium.
- the fermentation was carried out as follows: 0.5 ml of a suspension of spores of the above-mentioned strain is added under sterile conditions to 40 ml of inoculum medium in a 300 ml baffled Erlenmeyer flask.
- the inoculum medium consists of 10 g / 1 of Corn Steep, 15 g / 1 of sucrose, 10 g / 1 of (NH4) 2 SO4, 1 g / 1 of K2HPO4, 3 g / 1 of NaCl, 0.2 g / 1 of MgS ⁇ 4 ⁇ 7H2 ⁇ and 1.25 g / 1 of CaC ⁇ 3.
- the pH is adjusted to 6.9 with soda before the introduction of calcium carbonate.
- the Erlenmeyer flasks are agitated for 44 hours at 27 ° C. on a rotary agitator at the speed of 325 rpm.
- 2.5 ml of the preceding culture aged 44 hours is added sterile to 30 ml of production medium in a 300 ml Erlenmeyer flask.
- the production medium consists of 25 g / 1 of soy flour, 7.5 g / 1 of starch, 22.5 g / 1 of glucose, 3.5 g / 1 of yeast, 0.5 g / 1 zinc sulfate and 6 g / 1 calcium carbonate.
- the pH is adjusted to 6.0 with hydrochloric acid before the introduction of calcium carbonate.
- the Erlenmeyer flasks are agitated at 27 ° C. on a rotary agitator at the speed of 325 rpm.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/981,038 US5969179A (en) | 1995-06-12 | 1996-06-10 | Method for preparing enantiomeric forms of amino alkylaminophenyl propanoic acid |
JP9502697A JPH11509182A (ja) | 1995-06-12 | 1996-06-10 | 鏡像異性型のアミノアルキルアミノフェニルプロパン酸の製造方法 |
DK96922085T DK0837843T3 (da) | 1995-06-12 | 1996-06-10 | Fremgangsmåde til fremstilling af enantiomere former af aminoalkylaminophenylpropansyre |
DE69615195T DE69615195T2 (de) | 1995-06-12 | 1996-06-10 | Verfahren zur herstellung von enantiomeren der aminoalkylaminophenylpropansäure |
AU63083/96A AU6308396A (en) | 1995-06-12 | 1996-06-10 | Method for preparing enantiomeric forms of amino alkylaminop henyl propanoic acid |
BR9608974A BR9608974A (pt) | 1995-06-12 | 1996-06-10 | Processo de preparação de uma forma enantiómera do ácido amino-2 (alquilamino-4 fenil)-3 propanóico e utilização desta forma |
EP96922085A EP0837843B1 (fr) | 1995-06-12 | 1996-06-10 | Procede de preparation des formes enantiomeres de l'acide amino alkylaminophenyl propanoique |
AT96922085T ATE205471T1 (de) | 1995-06-12 | 1996-06-10 | Verfahren zur herstellung von enantiomeren der aminoalkylaminophenylpropansäure |
SK1701-97A SK170197A3 (en) | 1995-06-12 | 1996-06-10 | Method for preparing enantiomeric forms of amino alkylaminophenyl propanoic acid |
NO975150A NO975150L (no) | 1995-06-12 | 1997-11-10 | Fremgangsmåte for fremstilling av enantiomere former av aminoalkylaminofenylpropansyre |
MXPA/A/1997/008753A MXPA97008753A (en) | 1995-06-12 | 1997-11-13 | Procedure for preparation of breast ways of the amino acid alkylaminofenilo proparano |
GR20010400340T GR3036612T3 (en) | 1995-06-12 | 2001-09-13 | Method for preparing enantiomeric forms of amino alkylaminophenyl propanoic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9506890A FR2735126B1 (fr) | 1995-06-12 | 1995-06-12 | Procede de preparation des formes enantiomeres de l'acide amino alkylaminophenylpropanoique |
FR95/06890 | 1995-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996041794A1 true WO1996041794A1 (fr) | 1996-12-27 |
Family
ID=9479840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1996/000872 WO1996041794A1 (fr) | 1995-06-12 | 1996-06-10 | Procede de preparation des formes enantiomeres de l'acide amino alkylaminophenyl propanoique |
Country Status (23)
Country | Link |
---|---|
US (1) | US5969179A (fr) |
EP (1) | EP0837843B1 (fr) |
JP (1) | JPH11509182A (fr) |
KR (1) | KR19990022841A (fr) |
AR (1) | AR002468A1 (fr) |
AT (1) | ATE205471T1 (fr) |
AU (1) | AU6308396A (fr) |
BR (1) | BR9608974A (fr) |
CA (1) | CA2220403A1 (fr) |
CZ (1) | CZ399497A3 (fr) |
DE (1) | DE69615195T2 (fr) |
DK (1) | DK0837843T3 (fr) |
ES (1) | ES2164252T3 (fr) |
FR (1) | FR2735126B1 (fr) |
GR (1) | GR3036612T3 (fr) |
HU (1) | HUP9900051A3 (fr) |
IL (1) | IL122531A0 (fr) |
NO (1) | NO975150L (fr) |
PT (1) | PT837843E (fr) |
SK (1) | SK170197A3 (fr) |
TW (1) | TW415930B (fr) |
WO (1) | WO1996041794A1 (fr) |
ZA (1) | ZA964931B (fr) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU204026B (en) * | 1984-03-12 | 1991-11-28 | Alkaloida Vegyeszeti Gyar | Process for producing di-beta-substituted phenylamino acids |
-
1995
- 1995-06-12 FR FR9506890A patent/FR2735126B1/fr not_active Expired - Fee Related
-
1996
- 1996-06-10 DE DE69615195T patent/DE69615195T2/de not_active Expired - Fee Related
- 1996-06-10 CA CA002220403A patent/CA2220403A1/fr not_active Abandoned
- 1996-06-10 SK SK1701-97A patent/SK170197A3/sk unknown
- 1996-06-10 ZA ZA964931A patent/ZA964931B/xx unknown
- 1996-06-10 US US08/981,038 patent/US5969179A/en not_active Expired - Fee Related
- 1996-06-10 BR BR9608974A patent/BR9608974A/pt not_active Application Discontinuation
- 1996-06-10 JP JP9502697A patent/JPH11509182A/ja not_active Ceased
- 1996-06-10 CZ CZ973994A patent/CZ399497A3/cs unknown
- 1996-06-10 AU AU63083/96A patent/AU6308396A/en not_active Abandoned
- 1996-06-10 KR KR1019970709310A patent/KR19990022841A/ko not_active Application Discontinuation
- 1996-06-10 AT AT96922085T patent/ATE205471T1/de not_active IP Right Cessation
- 1996-06-10 DK DK96922085T patent/DK0837843T3/da active
- 1996-06-10 PT PT96922085T patent/PT837843E/pt unknown
- 1996-06-10 TW TW085106958A patent/TW415930B/zh active
- 1996-06-10 ES ES96922085T patent/ES2164252T3/es not_active Expired - Lifetime
- 1996-06-10 WO PCT/FR1996/000872 patent/WO1996041794A1/fr not_active Application Discontinuation
- 1996-06-10 IL IL12253196A patent/IL122531A0/xx unknown
- 1996-06-10 HU HU9900051A patent/HUP9900051A3/hu unknown
- 1996-06-10 EP EP96922085A patent/EP0837843B1/fr not_active Expired - Lifetime
- 1996-06-12 AR ARP960103117A patent/AR002468A1/es unknown
-
1997
- 1997-11-10 NO NO975150A patent/NO975150L/no not_active Application Discontinuation
-
2001
- 2001-09-13 GR GR20010400340T patent/GR3036612T3/el not_active IP Right Cessation
Non-Patent Citations (4)
Title |
---|
CHEMICAL ABSTRACTS, vol. 53, no. 13, 1959, Columbus, Ohio, US; abstract no. 12202g, F. BERGEL ET AL.: "Cytoactive amino acids and peptides. V. Derivatives of para-amino- and para-mercaptophenylalanine" XP002012680 * |
CHEMICAL ABSTRACTS, vol. 55, no. 22, 1961, Columbus, Ohio, US; abstract no. 22226g, B.L. MOLDAVER ET AL.: "Synthesis of some derivatives of beta-phenyl-DL-alanine" XP002012679 * |
J. CHEM. SOC., 1959, pages 90 - 97 * |
ZHUR. OBSHNEI KHIM., vol. 31, 1961, pages 1560 - 1569 * |
Also Published As
Publication number | Publication date |
---|---|
DE69615195D1 (de) | 2001-10-18 |
FR2735126A1 (fr) | 1996-12-13 |
HUP9900051A3 (en) | 2000-07-28 |
JPH11509182A (ja) | 1999-08-17 |
EP0837843B1 (fr) | 2001-09-12 |
IL122531A0 (en) | 1998-06-15 |
US5969179A (en) | 1999-10-19 |
PT837843E (pt) | 2001-12-28 |
ES2164252T3 (es) | 2002-02-16 |
SK170197A3 (en) | 1998-05-06 |
CZ399497A3 (cs) | 1998-07-15 |
ATE205471T1 (de) | 2001-09-15 |
ZA964931B (en) | 1997-01-08 |
AR002468A1 (es) | 1998-03-25 |
EP0837843A1 (fr) | 1998-04-29 |
KR19990022841A (ko) | 1999-03-25 |
DE69615195T2 (de) | 2002-07-04 |
CA2220403A1 (fr) | 1996-12-27 |
DK0837843T3 (da) | 2001-11-19 |
GR3036612T3 (en) | 2001-12-31 |
AU6308396A (en) | 1997-01-09 |
TW415930B (en) | 2000-12-21 |
FR2735126B1 (fr) | 1997-07-18 |
MX9708753A (es) | 1998-03-31 |
NO975150D0 (no) | 1997-11-10 |
NO975150L (no) | 1997-11-10 |
BR9608974A (pt) | 1999-02-02 |
HUP9900051A2 (hu) | 1999-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2342950C (fr) | Nouveau procede de preparation de la 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepine et application a la synthese de la tianeptine | |
EP0303546B1 (fr) | Procédé pour la O-alkylation de N-(hydroxy)aralkylphényléthanolamines | |
EP0309324A1 (fr) | Procédé de synthèse d'alpha amino N alkyles et de leurs esters. Application à la synthèse de carboxyalkyl dipeptides | |
WO1997020817A1 (fr) | Procede de separation de carbinols | |
EP1272454B1 (fr) | Procede de synthese des esters de la n-[(s)-1-carboxybutyl]-(s)-alanine et application a la synthese du perindopril | |
EP1268398B1 (fr) | Nouveau procede de synthese des esters de la n- (s)-1-carboxybutyl]-(s)-alanine et application a la synthese du perindopril | |
EP0303545B1 (fr) | Procédé pour la préparation de phényléthanolaminotétralines | |
FR2702220A1 (fr) | Dédoublement enzymatique de dérivés de 4-alkyl-2-pipéridine-carboxylate et utilisation des composés obtenus, comme intermédiaires de synthèse. | |
WO1996041794A1 (fr) | Procede de preparation des formes enantiomeres de l'acide amino alkylaminophenyl propanoique | |
WO1996038447A1 (fr) | Derives du 2-azabicyclo[2.2.1]heptane, leur preparation et leur application | |
EP1400531B1 (fr) | Procédé de synthèse de la N-[(S)-1-carbéthoxybutyl]-(S)-alanine et application à la synthèse du perindopril | |
EP1362845B1 (fr) | Nouveau procédé de synthèse des esters de la N-((S)-1-carboxybutyl)-(S)-alanine et application à la synthèse du perindopril | |
EP0915867B1 (fr) | Derives du thienylcyclohexane pour la synthese de thienylcyclohexyles | |
JPH0751090A (ja) | 光学活性3−アミノブタン酸の製造法及びそのエステル中間体 | |
JPH0649005A (ja) | ビニルグリシン(2−アミノ−3−ブテン酸)の簡単な製造方法および誘導体の簡便な分割 | |
EP1403278B1 (fr) | Procédé de synthèse de la N-((S)-1-carbéthoxybutyl)-(S)-alanine et application à la synthèse du perindopril | |
WO2002006209A1 (fr) | Procede de synthese de la n1, n3-bis (2-aminoethyl)propane-1,3-diamine, intermediaires de synthese, produits ainsi obtenus et leur application a la synthese de cyclam | |
EP2772547A1 (fr) | Procédé de synthèse enzymatique de l'acide (7S) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique et application à la synthèse de l'ivabradine et de ses sels | |
MXPA97008753A (en) | Procedure for preparation of breast ways of the amino acid alkylaminofenilo proparano | |
EP1140842A1 (fr) | Esters d'alkyle de l'acide 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionique utiles comme intermediaire | |
EP0828740A1 (fr) | Derives du 2-azabicyclo(2.2.1)heptane, leur preparation et leur application | |
LU84567A1 (fr) | Procede de preparation de derives heterocycliques d'acide acetique | |
FR2629453A1 (fr) | Procede pour la preparation de phenylethanolaminotetralines | |
FR2619379A1 (fr) | Procede pour la o-alkylation de n-(hydroxy) aralkyl-phenylethanolamines | |
FR2619378A1 (fr) | Procede pour la preparation de phenylethanolaminotetralines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AU BB BG BR CA CN CZ EE GE HU IL IS JP KP KR LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK TR TT UA US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1997/008753 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2220403 Country of ref document: CA Kind code of ref document: A Ref document number: 2220403 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996922085 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1997 502697 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 170197 Country of ref document: SK Ref document number: PV1997-3994 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08981038 Country of ref document: US Ref document number: 1019970709310 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1996922085 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1997-3994 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970709310 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1997-3994 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996922085 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019970709310 Country of ref document: KR |